| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| EVHEvolent Health, Inc. | $535.9M | — | $1.88B | -26.6% | -$534.51M | $115.7M | $966.47M | AI pending |
| ROMARoma Green Finance Ltd | $535.49M | — | HK$9.49M | -22.2% | -HK$27.32M | HK$6.9M | — | AI pending |
| ARTVArtiva Biotherapeutics, Inc. | $534.37M | — | $0 | -100.0% | -$83.87M | $301.45M | — | AI pending |
| PANLPangaea Logistics Solutions Ltd. | $532.96M | 11.1× | $632.04M | +17.8% | $19.37M | $105.68M | $38.52M | AI pending |
| ARKOARKO Corp. | $532.88M | 62.6× | $7.64B | -12.5% | $22.74M | $245.56M | $674.51M | Undervalued |
| SDSandridge Energy Inc | $532.4M | 6.4× | $156.36M | +24.8% | $70.2M | $113.35M | $0 | AI pending |
| NVECNve Corp | $531.56M | 29.5× | $1.11M | -10.7% | $15.2M | $2.9M | — | AI pending |
| QUADQuad/Graphics, Inc. | $530.96M | 16.5× | $2.42B | -9.4% | $27M | $7M | $433.2M | AI pending |
| CABACabaletta Bio, Inc. | $530.68M | — | — | — | — | $225.1M | — | AI pending |
| VREOFVireo Growth Inc. | $530.2M | — | $268.77M | +170.4% | -$68.11M | $122.7M | $58.21M | AI pending |
| DDD3d Systems Corp | $530.01M | — | $386.9M | -12.1% | $29.88M | $127.95M | $91.18M | AI pending |
| ESEAEuroseas Ltd. | $529.37M | 3.9× | $227.87M | +7.0% | $136.97M | $176.46M | $216.81M | AI pending |
| PRLDPrelude Therapeutics Inc | $529.1M | — | $12.14M | +73.4% | -$99.5M | $26.33M | — | AI pending |
| BDNBrandywine Realty Trust | $528.97M | — | $484.45M | -4.2% | -$178.25M | $36.2M | $2.62B | AI pending |
| BWFGBankwell Financial Group, Inc. | $528.54M | 12.4× | $2.83M | +44.0% | $35.2M | $203.4M | — | AI pending |
| CLMBClimb Global Solutions, Inc. | $527.72M | 25.4× | $652.52M | +40.1% | $21.33M | $56.56M | $0 | AI pending |
| OLPOne Liberty Properties Inc | $527.51M | 15.3× | $82.74M | +1.0% | $38.86M | $13.09M | — | AI pending |
| IPIIntrepid Potash, Inc. | $524.54M | 39.4× | $298.33M | +17.1% | $11.19M | $184.99M | $0 | AI pending |
| OISOil States International, Inc | $521.79M | — | $668.99M | -3.4% | -$109.38M | $19.8M | $18.43M | AI pending |
| KYTXKyverna Therapeutics, Inc. | $520.72M | — | — | — | — | $31.81M | $24.88M | AI pending |